Literature DB >> 6637768

Effect of ventricular pacing on left ventricular function assessed by radionuclide angiography.

C A Boucher, G M Pohost, R D Okada, F H Levine, H W Strauss, J W Harthorne.   

Abstract

Radionuclide angiography was used to evaluate left ventricular contraction on and off ventricular pacing in 35 patients. Twenty patients had permanent rate-adjustable ventricular demand pacemakers whose rate could be programmed to below an underlying sinus rhythm. In these patients there was no difference in left ventricular ejection fraction on and off pacing whether or not heart failure was present (n = 7) or whether or not ventriculoatrial conduction (n = 10) developed during pacing. Eight of the 20 patients also underwent supine bicycle exercise, and rest and exercise ejection fraction values were not significantly different at a similar heart rate and workload when on and off pacing were compared. During pacing, there appeared to be abnormal motion in septal, apical, and inferior walls. In addition, dysynchrony developed, consisting of early right ventricular and anterobasal and posterobasal left ventricular motion with subsequent contraction of the apex. Conversion to atrioventricular pacing produced a clinical improvement in all seven patients with heart failure and reduced ejection fraction and also in one of the remaining 13 patients without heart failure. Fifteen other patients were studied early after cardiac surgery. Temporary ventricular epicardial pacing resulted in a significant increase in right and left atrial pressure and a significant reduction in stroke volume, end-diastolic volume, and end-systolic volume with no significant change in ejection fraction. Conversion from sinus rhythm to ventricular pacing produces a deterioration in cardiac performance and severe regional left ventricular wall motion abnormalities, but no significant change in ejection fraction.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1983        PMID: 6637768     DOI: 10.1016/0002-8703(83)90659-2

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  7 in total

1.  Selective site pacing: rationale and practical application.

Authors:  Sameer Parekh; Kenneth M Stein
Journal:  Curr Cardiol Rep       Date:  2008-09       Impact factor: 2.931

2.  Global and regional wall motion abnormalities of pacing-induced heart failure assessed by multi-detector row CT: a patient and canine model study.

Authors:  I-Chen Tsai; Jin-Long Huang; Kwo-Chang Ueng; Yi-Wen Hung; Chin-Fang Hung; Wan-Chun Liao; Ho-Yi Lei; Min-Chi Chen; Wei-Lin Tsai; Shih-Ann Chen; Clayton Chi-Chang Chen; Yun-Ching Fu; Chih-Tai Ting
Journal:  Int J Cardiovasc Imaging       Date:  2010-08-21       Impact factor: 2.357

3.  Correlations of left ventricular diastolic parameters and heart rate: assessment through right ventricular pacing.

Authors:  Z X He; J Darcourt; J P Camous; J Benoliel; O Migneco; F Bussière-Lapalus; M Baudouy; P Morand
Journal:  Eur J Nucl Med       Date:  1992

4.  Cardiac Pacing for Bradycardia Support: Evidence-based Approach to Pacemaker Selection and Programming.

Authors:  Israel Galtes; Gervasio A. Lamas
Journal:  Curr Treat Options Cardiovasc Med       Date:  2004-10

5.  Incidence of atrial fibrillation and thromboembolism in a randomised trial of atrial versus dual chamber pacing in 177 patients with sick sinus syndrome.

Authors:  L Kristensen; J C Nielsen; P T Mortensen; O L Pedersen; A K Pedersen; H R Andersen
Journal:  Heart       Date:  2004-06       Impact factor: 5.994

6.  Asynchrony of ventricular activation affects magnitude and timing of fiber stretch in late-activated regions of the canine heart.

Authors:  Benjamin A Coppola; James W Covell; Andrew D McCulloch; Jeffrey H Omens
Journal:  Am J Physiol Heart Circ Physiol       Date:  2007-04-20       Impact factor: 4.733

Review 7.  The role of pacing in rhythm control and management of atrial fibrillation.

Authors:  John Silberbauer; Neil Sulke
Journal:  J Interv Card Electrophysiol       Date:  2007-05-02       Impact factor: 1.759

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.